Joan Puig de Dou

Joan Puig de Dou
  • Active in the pharmaceutical marketing for over 30 years
  • President of CataloniaBIO&HealthTech
  • CEO and Qualified Person at Kymos
  • Leader of Kymos team, guaranteeing a  trustable, ethical and scientific correct editorial publications.

Experience
Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&HealthTech to represent the Catalonian biotech industry nationally and internationally.

Expertise
Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader’s level of expertise. He publishes regularely on Kymos’ webpage, social media and in the specialized press.

Education
He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School’s Programa Diección General (PDG)

Want to know him better?
Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Scíentific de Barcelona.

  • bioequivalence studies Europe

Bioequivalence studies in Europe

June 22nd, 2022|Comments Off on Bioequivalence studies in Europe

Bioequivalence studies are designed to show that two drugs are equivalent and substitutable. - But even though the medicines are replaceable, the providers of bioequivalence studies are not. Digna Tost, Department Manager of Bioanalysis (...)

Read more

  • Kymos supports Ukraine

KYMOS SUPPORTS UKRAINIAN PEOPLE

June 14th, 2022|Comments Off on KYMOS SUPPORTS UKRAINIAN PEOPLE

From Kymos Group we have joined to the expressions of the international community condemning the military intervention of the Russian army against the Ukrainian population, as well as the demand for an end to the (...)

Read more

  • prostaglandine

Prolytic and Aeterna Zentaris – 20 years of improving human health together

March 22nd, 2022|Comments Off on Prolytic and Aeterna Zentaris – 20 years of improving human health together

For almost 20 years, Kymos’ German subsidiary Prolytic has accompanied Aeterna Zentaris in its development of pharmaceutical and diagnostic products. Katrin Dorfmeyer, Head of Chromatography, at Prolytic, and Dr. Michael Teifel, CSO at Aeterna Zentaris, (...)

Read more

Get in touch


    EU Sites

    Kymos Group

    Barcelona
    Spain

    Prolytic

    Frankfurt
    Germany

    Pharmaprogress

    Ancona
    Italy

    EU Offices

    Paris
    France

    Basel
    Switzerland

    Milano
    Italy